logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Coffey, Matthew Clayton, Dr.
    Scientist born in March 1971
    Individual (1 offspring)
    Officer
    icon of calendar 2016-12-01 ~ dissolved
    OF - Director → CIF 0
  • 2
    Look, Kirk James
    Chief Financial Officer born in July 1971
    Individual (1 offspring)
    Officer
    icon of calendar 2012-11-09 ~ dissolved
    OF - Director → CIF 0
  • 3
    icon of address1167, Kensington Crescent N.w., Suite 210, Calgary, Alberta, T2n 1x7, Canada
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2016-04-06 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 3
  • 1
    Ball, Douglas Alan
    Chief Financial Officer born in March 1947
    Individual
    Officer
    icon of calendar 2012-02-13 ~ 2012-11-09
    OF - Director → CIF 0
  • 2
    Thompson, Bradley George, Dr.
    President & Ceo, Oncolytics Biotech Inc. born in December 1958
    Individual
    Officer
    icon of calendar 2012-02-13 ~ 2016-12-06
    OF - Director → CIF 0
  • 3
    Warrander, Alan
    Pharma/Biotech Business Consultant born in October 1952
    Individual (1 offspring)
    Officer
    icon of calendar 2011-05-24 ~ 2019-12-04
    OF - Director → CIF 0
parent relation
Company in focus

ONCOLYTICS BIOTECH (U.K.) LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Creditors
Current
-243,364 GBP2024-12-31
-243,364 GBP2023-12-31
Net Current Assets/Liabilities
-243,364 GBP2024-12-31
-243,364 GBP2023-12-31
Total Assets Less Current Liabilities
-243,364 GBP2024-12-31
-243,364 GBP2023-12-31
Net Assets/Liabilities
-243,364 GBP2024-12-31
-243,364 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
Retained earnings (accumulated losses)
-258,372 GBP2024-12-31
-258,372 GBP2023-12-31
Equity
-243,364 GBP2024-12-31
-243,364 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
1 shares2024-12-31
1 shares2023-12-31
Par Value of Share
Class 1 ordinary share
100 GBP2024-01-01 ~ 2024-12-31

  • ONCOLYTICS BIOTECH (U.K.) LTD
    Info
    Registered number 07645726
    icon of addressC/o Mccarthy Tetrault 1 Angel Court, 18th Floor, London EC2R 7HJ
    PRIVATE LIMITED COMPANY incorporated on 2011-05-24 and dissolved on 2025-05-06 (13 years 11 months). The company status is Dissolved.
    The last date of confirmation statement was made at 2024-05-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.